Heartbeam holds a performance score of 7 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.75, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Heartbeam's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heartbeam is expected to be smaller as well. Use Heartbeam coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Heartbeam.
Risk-Adjusted Performance
Fair
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Heartbeam unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
If you would invest 186.00 in Heartbeam on October 6, 2025 and sell it today you would earn a total of 57.00 from holding Heartbeam or generate 30.65% return on investment over 90 days. Heartbeam is currently generating 1.5882% in daily expected returns and assumes 16.2328% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Heartbeam, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days Heartbeam is expected to generate 22.44 times more return on investment than the market. However, the company is 22.44 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.
Heartbeam Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heartbeam's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heartbeam, and traders can use it to determine the average amount a Heartbeam's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0978
Best Portfolio
Best Equity
Good Returns
Average Returns
BEAT
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average Heartbeam is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heartbeam by adding it to a well-diversified portfolio.
Heartbeam Fundamentals Growth
Heartbeam Stock prices reflect investors' perceptions of the future prospects and financial health of Heartbeam, and Heartbeam fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heartbeam Stock performance.
Assessing Heartbeam's fundamental ratios provides investors with valuable insights into Heartbeam's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Heartbeam is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Things to note about Heartbeam performance evaluation
Checking the ongoing alerts about Heartbeam for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heartbeam help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Heartbeam appears to be risky and price may revert if volatility continues
Heartbeam has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (19.45 M) with profit before overhead, payroll, taxes, and interest of 0.
Heartbeam currently holds about 9.27 M in cash with (14.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16.
Heartbeam has a poorfinancial position based on the latest SEC disclosures
Roughly 24.0% of the company shares are held by company insiders
Evaluating Heartbeam's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Heartbeam's stock performance include:
Analyzing Heartbeam's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heartbeam's stock is overvalued or undervalued compared to its peers.
Examining Heartbeam's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Heartbeam's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heartbeam's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Heartbeam's stock. These opinions can provide insight into Heartbeam's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Heartbeam's stock performance is not an exact science, and many factors can impact Heartbeam's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.